Related references
Note: Only part of the references are listed.REST, a master transcriptional regulator in neurodegenerative disease
Jee-Yeon Hwang et al.
CURRENT OPINION IN NEUROBIOLOGY (2018)
Vaccine-based immunotherapeutic approaches to gliomas and beyond
Michael Weller et al.
NATURE REVIEWS NEUROLOGY (2017)
Alterations in cellular metabolome after pharmacological inhibition of Notch in glioblastoma cells
Ulf D. Kahlert et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Dopamine D2 receptor suppresses gastric cancer cell invasion and migration via inhibition of EGFR/AKT/MMP-13 pathway
Hongli Huang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
Glioma and microglia, a double entendre
Korneel Grauwet et al.
NATURE IMMUNOLOGY (2016)
Progress in glioma diagnosis, classification and treatment
Patrick Y. Wen et al.
NATURE REVIEWS NEUROLOGY (2016)
An expression based REST signature predicts patient survival and therapeutic response for glioblastoma multiforme
Jianfeng Liang et al.
SCIENTIFIC REPORTS (2016)
The REST remodeling complex protects genomic integrity during embryonic neurogenesis
Tamilla Nechiporuk et al.
ELIFE (2016)
TSPYL2 is an essential component of the REST/NRSF transcriptional complex for TGFβ signaling activation
M. T. Epping et al.
CELL DEATH AND DIFFERENTIATION (2015)
Cancer stem cells in glioblastoma
Justin D. Lathia et al.
GENES & DEVELOPMENT (2015)
Mir-21-Sox2 Axis Delineates Glioblastoma Subtypes with Prognostic Impact
Pratheesh Sathyan et al.
JOURNAL OF NEUROSCIENCE (2015)
The Transcription Repressor REST in Adult Neurons: Physiology, Pathology, and Diseases
Pietro Baldelli et al.
ENEURO (2015)
Molecular Targeting of TRF2 Suppresses the Growth and Tumorigenesis of Glioblastoma Stem Cells
Yun Bai et al.
GLIA (2014)
Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastoma
Jie Li et al.
ONCOTARGET (2014)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
A REST derived gene signature stratifies glioblastomas into chemotherapy resistant and responsive disease
Matthew P. Wagoner et al.
BMC GENOMICS (2012)
Effects on promoter activity of common SNPs in 5′ region of GABRB3 exon 1A
Miyabi Tanaka et al.
EPILEPSIA (2012)
REST Is a Novel Prognostic Factor and Therapeutic Target for Medulloblastoma
Pete Taylor et al.
MOLECULAR CANCER THERAPEUTICS (2012)
A restricted cell population propagates glioblastoma growth after chemotherapy
Jian Chen et al.
NATURE (2012)
REST Controls Self-Renewal and Tumorigenic Competence of Human Glioblastoma Cells
Luciano Conti et al.
PLOS ONE (2012)
Repressor element-1 silencing transcription factor (REST)-dependent epigenetic remodeling is critical to ischemia-induced neuronal death
Kyung-Min Noh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
REST Regulates Oncogenic Properties of Glioblastoma Stem Cells
Mohamed M. Kamal et al.
STEM CELLS (2012)
Retinoic Acid Induces REST Degradation and Neuronal Differentiation by Modulating the Expression of SCFβ-TRCP in Neuroblastoma Cells
Akanksha Singh et al.
CANCER (2011)
NFKBIA Deletion in Glioblastomas.
Markus Bredel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
Jean-Martin Beaulieu et al.
PHARMACOLOGICAL REVIEWS (2011)
The Pathobiology of Glioma Tumors
Candece L. Gladson et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2010)
Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
Houtan Noushmehr et al.
CANCER CELL (2010)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Brain tumor stem cells: The cancer stem cell hypothesis writ large
Peter B. Dirks
MOLECULAR ONCOLOGY (2010)
Myoblast-Derived Neuronal Cells Form Glutamatergic Neurons in the Mouse Cerebellum
Vidya Gopalakrishnan et al.
STEM CELLS (2010)
SCG3 Transcript in Peripheral Blood Is a Prognostic Biomarker for REST-Deficient Small Cell Lung Cancer
Adrian C. Moss et al.
CLINICAL CANCER RESEARCH (2009)
The Rest Repression of the Neurosecretory Phenotype Is Negatively Modulated by BHC80, a Protein of the BRAF/HDAC Complex
Andrijana Klajn et al.
JOURNAL OF NEUROSCIENCE (2009)
Comparative genomics modeling of the NRSF/REST repressor network: From single conserved sites to genome-wide repertoire
Ali Mortazavi et al.
GENOME RESEARCH (2006)
Abnormal expression of REST/NRSF and Myc in neural stem/progenitor cells causes cerebellar tumors by blocking neuronal differentiation
XH Su et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
HS Phillips et al.
CANCER CELL (2006)
Distinct profiles of REST interactions with its target genes at different stages of neuronal development
YM Sun et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
The many faces of REST oversee epigenetic programming of neuronal genes
N Ballas et al.
CURRENT OPINION IN NEUROBIOLOGY (2005)
Conversion of myoblasts to physiologically active neuronal phenotype
Y Watanabe et al.
GENES & DEVELOPMENT (2004)
Activation of REST/NRSF target genes in neural stem cells is sufficient to cause neuronal differentiation
XH Su et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
The neuronal repressor REST/NRSF is an essential regulator in medulloblastoma cells
P Lawinger et al.
NATURE MEDICINE (2000)
REST-VP16 activates multiple neuronal differentiation genes in human NT2 cells
A Immaneni et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
